July 24-25 : 1st International Symposium on Intra-Tumoral Therapies in Lung Cancer | New York
1st International Symposium on Intra-Tumoral Therapies in Lung Cancer Event: 1st International Symposium on Intra-Tumoral Therapies in Lung Cancer Location: NYU Langone Health, New York Nanology le ...
June 22-25 : BIO International Convention | San Diego
BIO International Convention Event: BIO 2026 Location: San Diego Nanology leadership will be attending the Conference. To set up a meeting, email info@nanology.us Website:BIO International 2026
May 29-June 2 : ASCO Annual Meeting | Chicago
American Society of Clinical Oncology Annual Meeting Event: ASCO 2026 Location: Chicago Nanology leadership will be attending the Conference. To set up a meeting, email info@nanology.us Website:AS ...
April 17-22 : AACR 2026 | San Diego
American Association for Cancer Research Annual Meeting Event: AACR Annual Meeting Location: San Diego Nanology leadership will be attending the Conference. To set up a meeting, email info@nanology ...
April 9 : Cancer Progress | New York
Cancer Progress Event: Cancer Progress Location: New York Nanology leadership will be attending the Conference. To set up a meeting, email info@nanology.us Website:Cancer Progress
NanOlogy Appoints John M. Goldberg, MD as Chief Medical Officer to Further its Preclinical & Clinical Large Surface Area Microparticle Investigational Drug Portfolio
PRESS RELEASENanOlogy Appoints John M. Goldberg, MD as Chief Medical Officer to Further its Preclinical & Clinical Large Surface Area Microparticle Investigational Drug PortfolioFORT WORTH, Texas ...
NanOlogy Appoints David J. Arthur as Chief Executive Officer to Drive Clinical Development of its Large Surface Area Microparticle (LSAM) Investigational Drug Portfolio
PRESS RELEASENanOlogy Appoints David J. Arthur as Chief Executive Officer to Drive Clinical Development of its Large Surface Area Microparticle (LSAM) Investigational Drug Portfolio FORT WORTH, Texas, ...
NanOlogy Unveils Drug Development Program for Rare Pediatric Brainstem Tumor
PRESS RELEASE NanOlogy Unveils Drug Development Program for Rare Pediatric Brainstem Tumor Next Generation Intratumoral Technology Targets Diffuse Intrinsic Pontine Glioma Investigational New Drug ...
Therapeutic Advances in Medical Oncology: Systemic and locoregional therapies for cutaneous metastases from breast cancer: state of art and new frontiers in treatment approach
Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease April 18, ...
European Urology: A Systemic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder Cancer
Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease April 1 ...
Journal of Thoracic Oncology: Phase 2a Intratumoral Large Surface Area Microparticle Paclitaxel in Stage 3/4 Lung Cancer
Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease April 1 ...
JDDG: Cutaneous metastases: From epidemiology to therapy
Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease April 1 ...
Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease April 1 ...
NanOlogy Publishes Research Articles on the Immunomodulatory Effects of its Large Surface Area Microparticle Investigational Drugs
NanOlogy Publishes Research Articles on the Immunomodulatory Effects of its Large Surface Area Microparticle Investigational Drugs FORT WORTH (February 14, 2024) — NanOlogy LLC, a clinical-st ...
NanOlogy Clinical and Preclinical Immune Data Presented at NACLC and SITC
NanOlogy Clinical and Preclinical Immune Data Presented at NACLC and SITC Interim response and peripheral immunomodulation data from its Phase 2 clinical trial of IT LSAM-PTX in stage 3/4 lung ca ...